Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

HIV Infection

Free Subscription 15.09.2025 2 AIDS 2 AIDS Res Hum Retroviruses 1 Ann Intern Med 1 Cell 1 Clin Infect Dis 3 HIV Med 2 Int J Cancer 3 J Acquir Immune Defic Syndr 1 J Clin Invest 3 J Med Virol 1 JAMA 1 Lancet Infect Dis 1 Pediatr Infect Dis J 1 PLoS Biol 1 PLoS Comput Biol 1 PLoS Med 12 PLoS One 4 PLoS Pathog 2 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. SOULIE C, Balde A, Fofana D, Charpentier C, et al
   No evidence of an effect of the M184I/V on the doravirine/lamivudine/tenofovir switch efficacy in people living with HIV.
   AIDS. 2025 Sep 8. doi: 10.1097/QAD.0000000000004339.
   PubMed         Abstract available
   
   
2. ANNEQUIN M, Mora M, van Huizen R, Faye A, et al
   Structural factors associated with viral suppression among transgender women living with HIV in France.
   AIDS. 2025 Sep 8. doi: 10.1097/QAD.0000000000004337.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

3. 
   Corrigendum to: The Immunogenicity of AAV-Encoded HIV-1 bNAbs in Rhesus Macaques Is Unaffected by a Short Course of the Immunomodulator CTLA4Ig.
   AIDS Res Hum Retroviruses. 2025 Sep 10. doi: 10.1177/08892229251380258.
   PubMed        
   
   
4. ZHANG Z, Sun J, Yang H, Shi H, et al
   First Identification of a Novel HIV-1 CRF80_0107/B Recombinant Form Among Men Who Have Sex with Men in Hebei Province, China.
   AIDS Res Hum Retroviruses. 2025 Sep 8. doi: 10.1177/08892229251378021.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

5. FORSTER R, Schnure M, Jones J, Lesko C, et al
   The Potential Impact of Ending the Ryan White HIV/AIDS Program on HIV Incidence: A Simulation Study in 31 U.S. Cities.
   Ann Intern Med. 2025 Sep 9. doi: 10.7326/ANNALS-25-01737.
   PubMed         Abstract available
   
   

   
   Cell

6. DAS ADHIKARI U, Froehle LM, Pipkin AN, Baharlou H, et al
   Immunometabolic defects of CD8+ T cells disrupt gut barrier integrity in people with HIV.
   Cell. 2025 Sep 11:S0092-8674(25)00979-1. doi: 10.1016/j.cell.2025.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

7. MAINARDI I, Gerevini S, Tarantino A, Vercesi R, et al
   Changing clinical and laboratory characteristics of Progressive Multifocal Leukoencephalopathy: a retrospective national cohort study.
   Clin Infect Dis. 2025 Sep 9:ciaf501. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   HIV Med

8. OZDEMIR A, Demir T, Polat C, Uzun M, et al
   Molecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment-naive individuals with HIV-1 in Turkiye.
   HIV Med. 2025 Sep 7. doi: 10.1111/hiv.70109.
   PubMed         Abstract available
   
   
9. SHAIK F, Uldrick TS, Mazinu M, Gwebushe N, et al
   Cytokine biomarkers and their relationship to symptoms and quality of life in people with HIV-associated Kaposi sarcoma.
   HIV Med. 2025 Sep 10. doi: 10.1111/hiv.70107.
   PubMed         Abstract available
   
   
10. SHORT WR, Willame C, Nguyen H, Zhang B, et al
    Evaluating birth outcomes following oral rilpivirine use in pregnancy in the United States: Findings from the antiretroviral pregnancy registry.
    HIV Med. 2025 Sep 11. doi: 10.1111/hiv.70112.
    PubMed         Abstract available
    
    

    
    Int J Cancer

11. LIU H, Zou Z, Zhang L
    Reply to 'Comments on "HPV vaccination is highly effective and cost-effective for cervical cancer prevention in women living with HIV in China: A cost-effectiveness analysis"'.
    Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70129.
    PubMed        
    
    
12. LIU Z, Tong X
    Comments on "HPV vaccination is highly effective and cost-effective for cervical cancer prevention in women living with HIV in China: A cost-effectiveness analysis".
    Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70130.
    PubMed        
    
    

    
    J Acquir Immune Defic Syndr

13. MELNYCHUK S, Green K, Ejeckam C, Adesina A, et al
    HIV drug resistance among key populations in Nigeria: Insights from the 2020 integrated biological and behavioural surveillance survey.
    J Acquir Immune Defic Syndr. 2025 Sep 11. doi: 10.1097/QAI.0000000000003763.
    PubMed         Abstract available
    
    
14. STRACKER N, Rives S, Schumacher CM, Hamill MM, et al
    Addressing Health Disparities Associated with the HIV PrEP Initiation Cascade, Baltimore City Health Department Sexual Health Clinics, 2016-2023.
    J Acquir Immune Defic Syndr. 2025 Sep 11. doi: 10.1097/QAI.0000000000003764.
    PubMed         Abstract available
    
    
15. CARROZZO G, Pozza G, Poloni A, Caronni S, et al
    Evolution of causes of death in People with HIV between 2000 and 2023: a single center retrospective Study.
    J Acquir Immune Defic Syndr. 2025 Sep 10. doi: 10.1097/QAI.0000000000003762.
    PubMed        
    
    

    
    J Clin Invest

16. KOLOSSVARY M, Sereti I, Zanni MV, Fichtenbaum CJ, et al
    Statin-dependent and -independent pathways are associated with major adverse cardiovascular events in people with HIV.
    J Clin Invest. 2025 Sep 9:e196021. doi: 10.1172/JCI196021.
    PubMed         Abstract available
    
    

    
    J Med Virol

17. XIONG X, Yao Y, Li Y, Jiang Y, et al
    Global Burden and Economic Impact of HIV/AIDS and Other Sexually Transmitted Infections in Women of Childbearing Age, 1990-2021: Insights From the GBD 2021 Study.
    J Med Virol. 2025;97:e70599.
    PubMed         Abstract available
    
    
18. VILLOSLADA A, Rodriguez A, Sorni P, Serrano A, et al
    The Role of Human Papillomavirus Genotypes on Anal Squamous Intraepithelial Lesions Among Gay, Bisexual and Other Men Who Have Sex With Men Living With HIV: Beyond HPV-16.
    J Med Virol. 2025;97:e70596.
    PubMed         Abstract available
    
    
19. YALCIN D, Eymard ED, Kiran K, Kibanga W, et al
    Insights Into Kaposi Sarcoma-Associated Herpesvirus-Specific Humoral Responses.
    J Med Virol. 2025;97:e70597.
    PubMed         Abstract available
    
    

    
    JAMA

20. ASSOUMOU SA, Alexander RN, Miller SE
    Viral Infections Associated With Injection Drug Use.
    JAMA. 2025 Sep 10. doi: 10.1001/jama.2025.13287.
    PubMed        
    
    

    
    Lancet Infect Dis

21. METCALFE JZ, Weir IR, Scarsi KK, Mendoza-Ticona A, et al
    A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial.
    Lancet Infect Dis. 2025 Sep 4:S1473-3099(25)00436.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

22. TANUMA J, Jiamsakul A, Ross J, Lee MP, et al
    Pregnancy Outcomes After HIV Diagnosis in Women Living With HIV in Japan, South Korea and Hong Kong Special Administrative Region: A Brief Report.
    Pediatr Infect Dis J. 2025 Sep 10. doi: 10.1097/INF.0000000000004989.
    PubMed         Abstract available
    
    

    
    PLoS Biol

23. JALLOH S, Hughes IK, Akiyama H, Gojanovich AD, et al
    Expression of intron-containing HIV-1 RNA induces NLRP1 inflammasome activation in myeloid cells.
    PLoS Biol. 2025;23:e3003320.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

24. BURBACH SM, Briney B
    A curriculum learning approach to training antibody language models.
    PLoS Comput Biol. 2025;21:e1013473.
    PubMed         Abstract available
    
    

    
    PLoS Med

25. MUGWANY KK, Saina M, Mugo NR, MaWhinney S, et al
    Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study.
    PLoS Med. 2025;22:e1004732.
    PubMed         Abstract available
    
    

    
    PLoS One

26. TOLNO SA, Thys S, Keita AK, Tesch M, et al
    Rapid response to hemorrhagic fever emergence in Guinea: community-based systems can enhance engagement and sustainability.
    PLoS One. 2025;20:e0321164.
    PubMed         Abstract available
    
    
27. WYNN A, Harris D, Modest A, Reyes MF, et al
    Short-term costs and cost-efficiency of HPV triage strategies in a high HIV-prevalence setting: Evidence from Botswana.
    PLoS One. 2025;20:e0328803.
    PubMed         Abstract available
    
    
28. HAMOOYA BM, Siame L, Mutalange M, Cheelo C, et al
    Risk factors for Overweight/Obesity among people living with HIV on antiretroviral therapy: An ambidirectional cohort study at a tertiary health facility in Zambia.
    PLoS One. 2025;20:e0330777.
    PubMed         Abstract available
    
    
29. DEVANE D, Briel M, Bhagani S, Boesten N, et al
    Protocol for a core outcome set for pharmacological treatments in hospitalised patients with acute viral respiratory infections (COSAVRI).
    PLoS One. 2025;20:e0330288.
    PubMed         Abstract available
    
    
30. NAIT C, Ouma S, Ssentongo SM, Oryokot B, et al
    Prevalence and predictors of viral load non-suppression among adolescents on dolutegravir-based antiretroviral therapy: A cross-sectional study from three urban clinics, Soroti City.
    PLoS One. 2025;20:e0331835.
    PubMed         Abstract available
    
    
31. YANG C, Jiang X, Ren Y, Zhu X, et al
    Safety and contribution of elderly whole blood donors after raising the upper age limit: Hemovigilance data from a Chinese region from 2012 to 2023.
    PLoS One. 2025;20:e0331838.
    PubMed         Abstract available
    
    
32. VAUGHAN J, Patel M, Lawrie D, Machaba M, et al
    Correction: The prognostic impact of monocyte fluorescence, immunosuppressive monocytes and peripheral blood immune cell numbers in HIV-associated Diffuse Large B-cell Lymphoma.
    PLoS One. 2025;20:e0331945.
    PubMed         Abstract available
    
    
33. MSILANGA D, Muiru A, Msangi E, Shoo J, et al
    Point-of-care creatinine-based eGFR (StatSensor) in detecting kidney dysfunction (KD) among people living with HIV in Tanzania.
    PLoS One. 2025;20:e0331969.
    PubMed         Abstract available
    
    
34. DUAILIBE FT, Moore D, Hull M, Lima VD, et al
    Estimating the population size of gay, bisexual, and other men who have sex with men in four major provinces in Canada: A descriptive study using data from a population-based survey.
    PLoS One. 2025;20:e0330853.
    PubMed         Abstract available
    
    
35. JACOB N, Kalk E, Heekes A, Phelanyane F, et al
    The impact of evolving maternal antiretroviral therapy guidelines on vertical transmission of HIV in the Western Cape, South Africa.
    PLoS One. 2025;20:e0328612.
    PubMed         Abstract available
    
    
36. AMASA SNC, Beleta TMP, Montilla SL, Llantos OE, et al
    Simulating HIV transmission dynamics: An agent-based approach using NetLogo.
    PLoS One. 2025;20:e0330456.
    PubMed         Abstract available
    
    
37. ADJEI-ROGER J, Afagbedzi S, Tei-Maya E, Guure C, et al
    Evaluation of statistical regression models in predicting factors influencing HBV and HIV among female sex workers in Ghana: A Bio-behavioural survey.
    PLoS One. 2025;20:e0332152.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

38. PUERTAS MC, Bailon L, Urrea V, Garcia-Guerrero MC, et al
    Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy.
    PLoS Pathog. 2025;21:e1013466.
    PubMed         Abstract available
    
    
39. RIVAULT A, Bernut A, Ben-Neji M, Abrantes M, et al
    HIV-1 Tat favors the multiplication of Mycobacterium tuberculosis and Toxoplasma by inhibiting clathrin-mediated endocytosis and autophagy.
    PLoS Pathog. 2025;21:e1013183.
    PubMed         Abstract available
    
    
40. BUFFA DJ, O'Neil TR, Vine EE, Sarkawt L, et al
    Dendritic cells and HIV transmission: roles and subsets of antigen-presenting cells in the human anogenital tract.
    PLoS Pathog. 2025;21:e1013490.
    PubMed         Abstract available
    
    
41. COLLERCANDY N, Vellas C, Nayrac M, Requena M, et al
    Cytotoxic CX3CR1+ Vdelta1 T cells clonally expand in an interplay of CMV, microbiota, and HIV-1 persistence in people on antiretroviral therapy.
    PLoS Pathog. 2025;21:e1013489.
    PubMed         Abstract available
    
    

    
    Vaccine

42. ARSUFFI S, Rossi L, Colombo FR, Inverardi M, et al
    Herpes zoster reactivation in a cohort of people living with HIV vaccinated with recombinant vaccine.
    Vaccine. 2025;64:127723.
    PubMed         Abstract available
    
    
43. BOGA DJ, Robinson M, Tirupathi M, Juste RS, et al
    Latent class and time-to-event analyses of social determinants of health and COVID-19 vaccine uptake among Black women living with HIV.
    Vaccine. 2025;64:127649.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.